7,937 Shares in Agilent Technologies, Inc. $A Acquired by Texas Capital Bank Wealth Management Services Inc

Texas Capital Bank Wealth Management Services Inc bought a new position in Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 7,937 shares of the medical research company’s stock, valued at approximately $1,080,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Flynn Zito Capital Management LLC lifted its holdings in Agilent Technologies by 3.2% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after purchasing an additional 69 shares during the last quarter. Gabelli Funds LLC lifted its holdings in Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after purchasing an additional 74 shares during the last quarter. Fiduciary Trust Co lifted its holdings in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC lifted its holdings in Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after purchasing an additional 79 shares during the last quarter. Finally, Freestone Capital Holdings LLC lifted its holdings in Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after purchasing an additional 84 shares during the last quarter.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent posted second-quarter EPS of $1.49, topping estimates, while revenue rose 10% year over year to $1.83 billion, also ahead of forecasts. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its FY 2026 profit outlook, signaling management confidence in continued demand for medical tools, lab research equipment, and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Bank of America upgraded Agilent to Buy, citing strong execution, improving demand trends, and market share gains in key instrument categories. Agilent Technologies shares jump on earnings beat, Bank of America upgrade
• Positive Sentiment: TD Cowen and Barclays also raised price targets, adding to the positive analyst sentiment around the stock after the earnings release. Agilent Technologies Stock Soars On Broad Q2 Beat, Company Stands Out In Tools Sector
• Neutral Sentiment: Some commentary noted that recurring revenue reached 66% of sales, but that the stock had been under pressure earlier despite the earnings beat and higher guidance.

Agilent Technologies Stock Performance

NYSE A opened at $135.79 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The firm has a market capitalization of $38.37 billion, a price-to-earnings ratio of 27.27, a P/E/G ratio of 2.44 and a beta of 1.22. The company’s fifty day moving average is $115.45 and its two-hundred day moving average is $128.71. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The company had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.74%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Analysts Set New Price Targets

A has been the subject of several analyst reports. Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. UBS Group cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Morgan Stanley cut their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Royal Bank Of Canada began coverage on Agilent Technologies in a report on Wednesday. They set an “outperform” rating and a $153.00 price target for the company. Finally, Robert W. Baird upped their price target on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Buy” and an average target price of $160.93.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.